As of 2026-09-10, the Intrinsic Value of Repligen Corp (RGEN) is 42.68 USD. This RGEN valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 165.05 USD, the upside of Repligen Corp is -74.10%.
The range of the Intrinsic Value is 29.43 - 81.89 USD
Based on its market price of 165.05 USD and our intrinsic valuation, Repligen Corp (RGEN) is overvalued by 74.10%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 29.43 - 81.89 | 42.68 | -74.1% |
| DCF (Growth 10y) | 51.66 - 141.67 | 74.50 | -54.9% |
| DCF (EBITDA 5y) | 67.74 - 123.63 | 88.19 | -46.6% |
| DCF (EBITDA 10y) | 91.02 - 172.00 | 120.49 | -27.0% |
| Fair Value | 18.40 - 18.40 | 18.40 | -88.85% |
| P/E | 21.71 - 35.61 | 29.64 | -82.0% |
| EV/EBITDA | 51.29 - 92.83 | 75.36 | -54.3% |
| EPV | 9.58 - 11.80 | 10.69 | -93.5% |
| DDM - Stable | 8.63 - 31.89 | 20.26 | -87.7% |
| DDM - Multi | 35.04 - 100.36 | 51.91 | -68.5% |
| Market Cap (mil) | 9,315.42 |
| Beta | 1.49 |
| Outstanding shares (mil) | 56.44 |
| Enterprise Value (mil) | 9,259.68 |
| Market risk premium | 4.60% |
| Cost of Equity | 8.02% |
| Cost of Debt | 5.00% |
| WACC | 7.82% |